ACTA NEUROPHARMACOLOGICA ›› 2021, Vol. 11 ›› Issue (2): 5-10.DOI: 10.3969/j.issn.2095-1396.2021.02.002

Previous Articles     Next Articles

Differentiation of CD4+CD25- T Cells to Regulatory T Cells induced by Diosgenin in CIA Mice

LIANG Xiu-jun,YU Yong-zhou,XIA Dong-shuai,GAO Ya-xian,SUN Tong-you   

  1. 1 Chengde Medical UniversityChengde067000China

    2 Hebei Key Laboratory of Nerve Injury and RepairChengde 067000China

    3 Chengde Central HospitalChengde067000China

  • Online:2021-04-26 Published:2021-04-26
  • About author:梁秀军,女,讲师;研究方向:中药免疫;E-mail:149304426@qq.com
  • Supported by:
    河北省高等学校科学技术研究项目(No.QN2016031),河北省中医药管理局科研计划项目(No.2015155),河北省科技厅中央引导地方科技发展基金项目(No.216Z2501G

Abstract:

ObjectiveTo investigate the roles of diosgenin in the differentiation of regulatory T cells from CD4+CD25-T cells in collagen induced arthritis mice. Methods

CD4+CD25-T cells of CIA mice isolated by immunomagnetic beads on magnetic activated cell sorting device were co-cultured with different concentrations of diosgenin2512.56.25 μmol·L-1for 48 hours. The ratio of Treg cells was tested by flow cytometry. The level of Foxp3 mRNA was measured by Real-Time PCR. The level of serum IL-10 was detected by ELISA. ResultsThis study separated CD4+CD25-T cells of 93.89% purity. The ratio of Treg cellsthe level of IL-10 and Foxp3 mRNA were increased significantly in diosgenin groups compared with those in control groupP<0.05. ConclusionDiosgenin may induce the differentiation of CD4+CD25-T cells to regulatory T cells in CIA mice and up-regulate the expression of Foxp3.

Key words:

font-family:Times, "> CIA modelfont-family:Helvetica, ">;diosgeninfont-family:Helvetica, ">;regulatory T cells

CLC Number: